- Home
- SFHG vs SNGX Comparison
SFHG vs SNGX Comparison
Compare SFHG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- SNGX
- Stock Information
- Founded
- SFHG 1993
- SNGX 1987
- Country
- SFHG Hong Kong
- SNGX United States
- Employees
- SFHG N/A
- SNGX N/A
- Industry
- SFHG Publishing
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- SNGX Health Care
- Exchange
- SFHG Nasdaq
- SNGX Nasdaq
- Market Cap
- SFHG 11.7M
- SNGX 13.8M
- IPO Year
- SFHG 2024
- SNGX 1987
- Fundamental
- Price
- SFHG $0.42
- SNGX $1.48
- Analyst Decision
- SFHG
- SNGX Strong Buy
- Analyst Count
- SFHG 0
- SNGX 1
- Target Price
- SFHG N/A
- SNGX $6.00
- AVG Volume (30 Days)
- SFHG 586.7K
- SNGX 256.3K
- Earning Date
- SFHG 10-30-2025
- SNGX 11-07-2025
- Dividend Yield
- SFHG N/A
- SNGX N/A
- EPS Growth
- SFHG N/A
- SNGX N/A
- EPS
- SFHG N/A
- SNGX N/A
- Revenue
- SFHG $19,577,200.00
- SNGX N/A
- Revenue This Year
- SFHG N/A
- SNGX N/A
- Revenue Next Year
- SFHG N/A
- SNGX N/A
- P/E Ratio
- SFHG N/A
- SNGX N/A
- Revenue Growth
- SFHG 3.56
- SNGX N/A
- 52 Week Low
- SFHG $0.32
- SNGX $1.09
- 52 Week High
- SFHG $24.00
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- SFHG 37.30
- SNGX 47.15
- Support Level
- SFHG $0.35
- SNGX $1.25
- Resistance Level
- SFHG $0.50
- SNGX $1.47
- Average True Range (ATR)
- SFHG 0.07
- SNGX 0.11
- MACD
- SFHG 0.00
- SNGX 0.02
- Stochastic Oscillator
- SFHG 48.39
- SNGX 65.45
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).